Inhibition of lipopolysaccharide-induced inflammation by trophoblast-conditioned medium and trophoblast-derived extracellular vesicles in human middle ear epithelial cells.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
14 11 2023
Historique:
received: 19 05 2023
accepted: 04 11 2023
medline: 16 11 2023
pubmed: 15 11 2023
entrez: 14 11 2023
Statut: epublish

Résumé

Otitis media is a common disease but can cause severe inner ear inflammation and hearing loss if it persists for more than two weeks. This study elucidates the inflammation-inhibiting efficacy of conditioned medium (CM) and extracellular vesicles (EVs) derived from human trophoblast (TB) cells in lipopolysaccharide (LPS)-induced human middle ear epithelial cells (HMEECs). TB-conditioned medium (TB-CM) reduced the inflammatory response and regulated mucin and epithelial sodium channel genes in LPS-induced HMEECs. The underlying mechanism of cell migration during inflammatory healing in LPS-induced HMEECs treated with TB-CM was determined by RNA-sequencing analysis. Specifically, the NF-κB pathway related to the copper metabolism MURR1 domain protein was studied and verified through siRNA. This elucidation of the anti-inflammatory effect of TB-CM and TB-derived EVs demonstrates their clinical potential to treat chronic inflammation.

Identifiants

pubmed: 37963902
doi: 10.1038/s41598-023-46731-7
pii: 10.1038/s41598-023-46731-7
pmc: PMC10645728
doi:

Substances chimiques

Lipopolysaccharides 0
Culture Media, Conditioned 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

19822

Informations de copyright

© 2023. The Author(s).

Références

Eur J Pediatr. 2007 Jun;166(6):511-9
pubmed: 17364173
Pediatr Res. 2010 Sep;68(3):231-6
pubmed: 20531251
Annu Rev Physiol. 1995;57:607-34
pubmed: 7778880
Am J Physiol Lung Cell Mol Physiol. 2004 Feb;286(2):L301-11
pubmed: 14514522
Sci Rep. 2018 Jan 11;8(1):480
pubmed: 29323194
Gene. 2016 Apr 1;579(2):95-132
pubmed: 26772908
PLoS One. 2011;6(10):e26426
pubmed: 22039485
Cytotechnology. 2008 Sep;58(1):33-42
pubmed: 19002775
FASEB J. 2001 Jan;15(1):155-163
pubmed: 11149903
J Am Coll Nutr. 1996 Jun;15(3):206-22
pubmed: 8935436
Placenta. 1997 Nov;18(8):657-65
pubmed: 9364601
Prostaglandins Other Lipid Mediat. 2002 Aug;68-69:165-75
pubmed: 12432916
Eur J Pharmacol. 2007 Jul 12;567(1-2):19-25
pubmed: 17499239
Biochim Biophys Acta. 2013 Dec;1832(12):2315-21
pubmed: 24080195
Front Cell Dev Biol. 2016 Aug 22;4:83
pubmed: 27597941
Biochem J. 2006 Aug 15;398(1):63-71
pubmed: 16573520
Am J Reprod Immunol. 2021 Mar;85(3):e13352
pubmed: 32969101
J Otol. 2019 Jun;14(2):33-39
pubmed: 31223299
Best Pract Res Clin Obstet Gynaecol. 2016 Feb;31:13-29
pubmed: 26547389
Clin Infect Dis. 1994 Nov;19(5):823-33
pubmed: 7893865
Int J Mol Sci. 2021 Jun 28;22(13):
pubmed: 34203413
Cell. 2019 Apr 4;177(2):428-445.e18
pubmed: 30951670
Cell. 2016 Mar 10;164(6):1226-1232
pubmed: 26967288
RNA. 2020 Aug;26(8):903-909
pubmed: 32284352
Stem Cell Res Ther. 2022 Jan 24;13(1):24
pubmed: 35073970
J Biol Chem. 2000 Mar 31;275(13):9377-84
pubmed: 10734081
Int J Pediatr Otorhinolaryngol. 2009 Nov;73(11):1589-93
pubmed: 19732969
Physiol Rev. 2006 Jan;86(1):245-78
pubmed: 16371599
Stem Cell Res Ther. 2019 Oct 17;10(1):301
pubmed: 31623677
J Clin Invest. 1999 Oct;104(7):R19-23
pubmed: 10510339
J Biol Chem. 2005 Jun 10;280(23):22222-32
pubmed: 15799966
Rheumatology (Oxford). 2010 Jul;49(7):1215-28
pubmed: 20194223
Nature. 2001 Dec 20-27;414(6866):916-20
pubmed: 11780065
Stem Cells. 2008 Feb;26(2):300-11
pubmed: 17975221
Laryngoscope. 2011 Feb;121(2):365-71
pubmed: 21271590
Cell Res. 2002 Mar;12(1):9-18
pubmed: 11942415
Int J Mol Sci. 2020 Jan 22;21(3):
pubmed: 31979113
J Extracell Vesicles. 2015 May 14;4:27066
pubmed: 25979354
Exp Hematol. 2005 Nov;33(11):1402-16
pubmed: 16263424
Cell Cycle. 2007 Mar 15;6(6):672-6
pubmed: 17361106
J Infect Dis. 2008 Dec 15;198(12):1862-9
pubmed: 18986247
Cell Prolif. 2021 Mar;54(3):e12993
pubmed: 33458899
Theranostics. 2020 Jul 9;10(18):8111-8129
pubmed: 32724461
Reprod Biol Endocrinol. 2007 Feb 08;5:6
pubmed: 17288592
Trends Mol Med. 2019 May;25(5):382-394
pubmed: 30853173

Auteurs

Chan Mi Lee (CM)

Division of Otorhinolaryngology-Head and Neck Surgery, Korea University College of Medicine, Seoul, Republic of Korea.

Yoon Young Go (YY)

Division of Otorhinolaryngology-Head and Neck Surgery, Korea University College of Medicine, Seoul, Republic of Korea.
Center for Health Care Convergence at Korea University Guro Hospital, Seoul, Republic of Korea.

Jae-Jun Song (JJ)

Division of Otorhinolaryngology-Head and Neck Surgery, Korea University College of Medicine, Seoul, Republic of Korea. jjsong23@gmail.com.
Center for Health Care Convergence at Korea University Guro Hospital, Seoul, Republic of Korea. jjsong23@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH